Moderna’s stock tumbles after reported leak of data for cancer vaccine

Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)